Abstract Body

Background: Current antiretroviral combination therapy is extremely effective in suppressing HIV-1 viremia but replication-competent HIV-1 can persist for extremely long-periods of time despite effective treatment with HAART. Defining the cell types that serve as a reservoir for long-term persistence of HIV-1 is critical for designing interventions that may at one point lead to HIV-1 eradication and cure. Stem cells represent the most long-lasting human cells and are maintained by specific molecular programs that induce self-renewal homeostatic proliferation and resistance against apoptotic cell death. Tissue-specific stem cells in particular hematopoietic stem cells have been proposed as long-term reservoirs for HIV-1 but their role for HIV-1 persistence remains controversial. A number of recent observations indicate that molecular stem cell programs are not exclusively active in classical organ-specific stem cells but also govern developmental programs of cellular immune memory. In fact recent data suggest that the process of memory T cell development originates from an exquisitely rare population of T cells with stem cell-like properties. These cells termed T memory stem cells likely represent the earliest and most immature developmental stage of memory T cells and have recently been described in humans mice and non-human primates. Functionally T memory stem cells exceed the proliferative capacity of all known alternative memory T cell subsets and can differentiate into large numbers of mature effector T cells while maintaining their own pool size through homeostatic self-renewal. Due to these characteristics CD4 T memory stem cells may represent a preferred cellular niche for HIV-1 persistence during suppressive antiretroviral therapy. Conclusions: Our data suggest that CD4 T memory stem cells are susceptible to HIV-1 and harbor high levels of HIV-1 DNA in HIV-1 infected patients treated with suppressive HAART. In addition we show that HIV-1 DNA levels in these cells remain stable for many of antiretroviral therapy and that the relative contribution of these cells to the total viral reservoir increases over time. As such HIV-1 infected CD4 T memory stem cells may represent a stem-cell like reservoir for HIV-1 that has a similar function for maintaining HIV-1 persistence as cancer stem cells have for perpetuating certain oncologic diseases. The increasing understanding of how stem cell-like properties of cellular immune memory support HIV-1 persistence despite HAART may be translatable into improved clinical strategies for inducing HIV-1 eradication.